Lygos
PrivateLast Round
Convertible Debt
Apr 18, 2022
Total Funding Raised
$206.37M
Company Overview
Lygos is a biotechnology company that engineers microbes to convert plant-based sugars into high-value, bio-based specialty chemicals and polymers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Advanced Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lygos Comparables
Compare Lygos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DMC Biotechnologies | 80% | |
| Ecovia Bio | 79% | |
| Manus Bio | 77% |
Lygos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 18, 2022 | ||||
| Strategic | Feb 9, 2021 | ||||
| Series B Extension | Sep 16, 2019 | ||||
| Grant | Jun 3, 2019 | ||||
| Grant | Mar 11, 2019 | ||||
Series B Extension | Jan 24, 2019 |
Key People
Founding team and executive leadership
Lygos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vast Ventures | Series A |
| LG Technology Ventures | Series B, Series B Extension |
| IA Ventures | Series B, Series A |
| First Round Capital | Series A, Series B |
| Vast Ventures | Series A |
| Y Combinator | Seed |
| OS Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
Added IndSpyre Solutions, Inc. from the Chemicals industry.
- May 6, 2024
Collaboration with CJ Bio to build a biorefinery in Iowa.
Lygos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lygos's valuation, stock price, and market status.
Is Lygos a public or private company?
Lygos is a private company.
What is the current stock price of Lygos?
Lygos is a private company with no public stock price. No recent secondary market data is available.
How much is Lygos worth (valuation)?
Valuation information for Lygos is not publicly available.
Can I buy Lygos stock?
Lygos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lygos's last funding round?
Lygos's most recent funding round was Convertible Debt on April 18, 2022.
Who are the main investors in Lygos?
Key investors in Lygos include IA Ventures, First Round Capital, Y Combinator, OS Fund, Flexible Solutions International.
Will Lygos IPO soon?
No public IPO plans have been announced for Lygos.
How can I track Lygos secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lygos's secondary market activity and sign up for updates.